Viral vectors are a critical tool for biopharma companies both in the lab and in the clinic. The teams that specialize in vector production are the linchpin of many R&D organizations, but they struggle with several key challenges, such as siloed and disconnected data, complex hand-offs between teams, and DNA design errors that cause bottlenecks and delays.
In this webinar, we provide:
- An overview and live demonstration of the Benchling platform and how it’s used by leading biopharma organizations involved in viral vector production
- Best practices to increase the efficiency of DNA design, centralize and optimize production processes, and streamline data and sample handoffs
- A fireside chat with Nikita Lim, Process Development Engineer at a leading gene therapy company, about how she’s worked with Benchling to bring her viral vector production into a class all its own